Dysregulated transcriptional responses to SARS-CoV-2 in the periphery MT McClain, FJ Constantine, R Henao, Y Liu, EL Tsalik, TW Burke, ... Nature communications 12 (1), 1079, 2021 | 87* | 2021 |
Incidence of Ductal Carcinoma In Situ in the United States, 2000–2014 MD Ryser, LH Hendrix, M Worni, Y Liu, T Hyslop, ES Hwang Cancer Epidemiology, Biomarkers & Prevention 28 (8), 1316-1323, 2019 | 38 | 2019 |
Growth dynamics of mammographic calcifications: differentiating ductal carcinoma in situ from benign breast disease LJ Grimm, MM Miller, SM Thomas, Y Liu, JY Lo, ES Hwang, T Hyslop, ... Radiology 292 (1), 77-83, 2019 | 29 | 2019 |
The host response to viral infections reveals common and virus-specific signatures in the peripheral blood EL Tsalik, C Fiorino, A Aqeel, Y Liu, R Henao, ER Ko, TW Burke, ... Frontiers in immunology 12, 741837, 2021 | 21 | 2021 |
Independent community pharmacists’ experience in offering pharmacogenetic testing SB Haga, R Mills, J Moaddeb, Y Liu, D Voora Pharmacogenomics and Personalized Medicine, 877-886, 2021 | 13 | 2021 |
UV irradiation remodels the specificity landscape of transcription factors Z Mielko, Y Zhang, H Sahay, Y Liu, MA Schaich, B Schnable, AM Morrison, ... Proceedings of the National Academy of Sciences 120 (11), e2217422120, 2023 | 9 | 2023 |
Incorporating Prior Knowledge into Neural Networks through an Implicit Composite Kernel Z Jiang, T Zheng, Y Liu, D Carlson arXiv preprint arXiv:2205.07384, 2022 | 8 | 2022 |
Modeling statin myopathy in a human skeletal muscle microphysiological system A Ananthakumar, Y Liu, CE Fernandez, GA Truskey, D Voora Plos one 15 (11), e0242422, 2020 | 6 | 2020 |
Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory SB Haga, Y Liu Pharmacogenomics 20 (8), 581-587, 2019 | 6 | 2019 |
Estimating causal effects using a multi-task deep ensemble Z Jiang, Z Hou, Y Liu, Y Ren, K Li, D Carlson International Conference on Machine Learning, 15023-15040, 2023 | 5 | 2023 |
Host gene expression to predict sepsis progression C Fiorino, Y Liu, R Henao, ER Ko, TW Burke, GS Ginsburg, MT McClain, ... Critical care medicine 50 (12), 1748-1756, 2022 | 5 | 2022 |
Delivery of pharmacogenetic testing with or without medication therapy management in a community pharmacy setting SB Haga, R Mills, J Moaddeb, Y Liu, D Voora Pharmacogenomics and Personalized Medicine, 785-796, 2021 | 4 | 2021 |
Domain adaptation via rebalanced sub-domain alignment Y Liu, J Dong, Z Jiang, A Aloui, K Li, H Klein, V Tarokh, D Carlson arXiv preprint arXiv:2302.02009, 2023 | 2 | 2023 |
1023. Host gene expression biomarkers to distinguish between causes of acute respiratory symptoms in lung transplant recipients JM Steinbrink, Y Liu, A Gray, O Mohamedaly, B Zick, MT McClain Open Forum Infectious Diseases 8 (Suppl 1), S603, 2021 | 1 | 2021 |
Causal Mediation Analysis with Multi-dimensional and Indirectly Observed Mediators Z Jiang, Y Liu, MH Klein, A Aloui, Y Ren, K Li, V Tarokh, D Carlson arXiv preprint arXiv:2306.07918, 2023 | | 2023 |
Metabolomic Profiling of Engineered Skeletal Myobundles Identifies a Plasma Biomarker for Statin Associated Musculoskeletal Symptoms (SAMS) Y Liu, A Ananthakumar, W Thompson, R Myers, R Kaddurah-Daouk, ... Circulation 140 (Suppl_1), A15680-A15680, 2019 | | 2019 |